Skip to content

PTHS PTHS Total Revenue

Total Revenue at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$9.13M-22.0%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$15.96M+21.5%
Opko Health logo
Opko HealthOPK
$124.2M-17.2%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$36.22M+77.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$17.7M+15.0%
HRO
HarrowHROW
$44.2M-7.6%

Segments

By segment

See full
Commercial operations$10.67M
Research and Development operations$241K

Other financials

Income statement

See full
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's total revenue?
PTHS (PTHS) reported total revenue of $10.91M in Q1 2026.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.